SCHEMBL244418

SCHEMBL244418

CCC(C)(C)c1ccc([I+]c2ccc(C(C)(C)CC)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
MAPT P10636 1/20 0.47
CNR2 P34972 2/20 0.42
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
CASP3 P42574 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
HRH3 Q9Y5N1 12/20 0.38
MAOB P27338 8/20 0.38
ADORA3 P0DMS8 1/20 0.36
CHRM1 P11229 1/20 0.36
DRD3 P35462 1/20 0.36
KCNH2 Q12809 1/20 0.36
POLB P06746 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL5175328 1.00 NPC1 (0.47) NPC1RAB9AMAPTCNR2LMNA
SCHEMBL10123416 0.94 NPC1 (0.43) NPC1RAB9AMAPTCNR2LMNA
SCHEMBL30370226 0.92 NPC1 (0.42) NPC1RAB9AMAPTCNR2LMNA
Sulfuric Acid SCHEMBL4384843 0.88 NPC1 (0.41) NPC1RAB9AMAPTCNR2LMNA
Sulfuric Acid SCHEMBL2920577 0.88 NPC1 (0.41) NPC1RAB9AMAPTCNR2LMNA
Acetic Acid SCHEMBL2914240 0.87 NPC1 (0.39) NPC1RAB9AMAPTCNR2LMNA
Sulfuric Acid SCHEMBL2920580 0.85 NPC1 (0.39) NPC1RAB9AMAPTCNR2LMNA
SCHEMBL779443 0.84 NPC1 (0.58) NPC1RAB9AMAPTCNR2LMNA
SCHEMBL4624075 0.80 NPC1 (0.44) NPC1RAB9AMAPTHRH3MAOB
SCHEMBL4623961 0.79 HRH3 (0.41) NPC1RAB9AMAPTLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 419 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9221928-B2 Fluorine-containing sulfonate resin, fluorine-containing N-sulfonyloxyimide resin, resist composition and pattern formation method CENTRAL GLASS COMPANY, LIMITED (JP) 2015-12-29 US claimed
EP-1710230-B1 Novel sulfonate salts and derivatives, photoacid generators, resist compositions, and patterning process SHINETSU CHEMICAL CO (JP) 2013-08-14 EP claimed
EP-2362268-B1 Polymer, chemically amplified positive resist compositions and pattern forming process SHINETSU CHEMICAL CO (JP) 2013-01-23 EP claimed
EP-1780199-B1 Novel fluorohydroxyalkyl sulfonate salts and derivatives, photoacid generators, resist compositions, and patterning process SHINETSU CHEMICAL CO (JP) 2012-02-01 EP claimed
EP-1780198-B1 Novel fluorosulfonyloxyalkyl sulfonate salts and derivatives, photoacid generators, resist compositions, and patterning process SHINETSU CHEMICAL CO (JP) 2011-10-05 EP claimed
US-12585186-B2 Photoacid generator, chemically amplified resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-03-24 US disclosed
US-20230384677-A1 ONIUM SALT COMPOUND, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-11-30 US disclosed
CN-116954024-A Chemically amplified positive resist composition and method for forming resist pattern 信越化学工业株式会社 2023-10-27 CN disclosed
US-20230314943-A1 CHEMICALLY AMPLIFIED RESIST COMPOSITION AND METHOD FOR MANUFACTURING RESIST FILM USING THE SAME MERCK PATENT GMBH (DE) 2023-10-05 US disclosed
CN-110531580-B Chemically amplified negative resist composition and resist pattern forming method 信越化学工业株式会社 2023-08-29 CN disclosed
CN-111665684-B Positive resist composition and pattern forming method 信越化学工业株式会社 2023-08-25 CN disclosed
US-20230213858-A1 MANUFACTURING METHOD FOR CURED SUBSTANCE, MANUFACTURING METHOD FOR LAMINATE, AND MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE FUJIFILM CORPORATION (JP) 2023-07-06 US disclosed
US-20040245432-A1 Two-photon absorbing polymerization method, two-photon absorbing optical recording material and two-photon absorbing optical recording method FUJI PHOTO FILM CO., LTD. 2004-12-09 US disclosed
US-20040053158-A1 Onium salts and the use therof as latent acids CIBA SPECIALTY CHEMICALS CORP. 2004-03-18 US disclosed
EP-1344109-A2 ONIUM SALTS AND THE USE THEROF AS LATENT ACIDS Ciba SC Holding AG (CH) 2003-09-17 EP disclosed
WO-2002046507-A2 ONIUM SALTS AND THE USE THEROF AS LATENT ACIDS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-06-13 WO disclosed
US-5585425-A Thermochromic opaque/transparent composition, laminate member employing the same, and three-dimensional member employing said laminate member and capable of concealing and revealing the interior THE PILOT INK CO., LTD. (JP) 1996-12-17 US disclosed
US-5490956-A Thermochromic opaque composition, laminate member employing the same, and three-dimensional member employing said laminate member and capable of concealing and revealing the interior PILOT INK CO., LTD. (JP) 1996-02-13 US disclosed
EP-0677564-A2 Opaque/transparent thermochromic compositions and laminate THE PILOT INK CO., LTD. (JP) 1995-10-18 EP disclosed
EP-0595577-A2 Thermochromic opaque composition and uses thereof THE PILOT INK CO., LTD. (JP) 1994-05-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12585186-B2 Photoacid generator, chemically amplified resist composition, and patterning process LBR, LIFR, LEF1 NPC1 3652/4885RAB9A 2589/4885MAPT 4757/4885
US-20230384677-A1 ONIUM SALT COMPOUND, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS INSR, INSRR, SLC6A5 NPC1 3749/4885RAB9A 3054/4885MAPT 714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.